Your browser doesn't support javascript.
loading
Accessing the Cytotoxicity and Cell Response to Biomaterials.
Paula, Anabela Baptista; Laranjo, Mafalda; Coelho, Ana Sofia; Abrantes, Ana Margarida; Gonçalves, Ana Cristina; Sarmento-Ribeiro, Ana Bela; Ferreira, Manuel Marques; Botelho, Maria Filomena; Marto, Carlos Miguel; Carrilho, Eunice.
Afiliação
  • Paula AB; Institute of Integrated Clinical Practice, Faculty of Medicine, University of Coimbra, Coimbra, Portugal; Coimbra Institute for Clinical and Biomedical Research (iCBR) area of Environment Genetics and Oncobiology (CIMAGO), University of Coimbra, Coimbra, Portugal; Center for Innovative Biomedicine a
  • Laranjo M; Coimbra Institute for Clinical and Biomedical Research (iCBR) area of Environment Genetics and Oncobiology (CIMAGO), University of Coimbra, Coimbra, Portugal; Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, Coimbra, Portugal; Clinical Academic Center of Coimbra, CA
  • Coelho AS; Institute of Integrated Clinical Practice, Faculty of Medicine, University of Coimbra, Coimbra, Portugal; Coimbra Institute for Clinical and Biomedical Research (iCBR) area of Environment Genetics and Oncobiology (CIMAGO), University of Coimbra, Coimbra, Portugal; Center for Innovative Biomedicine a
  • Abrantes AM; Coimbra Institute for Clinical and Biomedical Research (iCBR) area of Environment Genetics and Oncobiology (CIMAGO), University of Coimbra, Coimbra, Portugal; Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, Coimbra, Portugal; Clinical Academic Center of Coimbra, CA
  • Gonçalves AC; Coimbra Institute for Clinical and Biomedical Research (iCBR) area of Environment Genetics and Oncobiology (CIMAGO), University of Coimbra, Coimbra, Portugal; Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, Coimbra, Portugal; Clinical Academic Center of Coimbra, CA
  • Sarmento-Ribeiro AB; Coimbra Institute for Clinical and Biomedical Research (iCBR) area of Environment Genetics and Oncobiology (CIMAGO), University of Coimbra, Coimbra, Portugal; Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, Coimbra, Portugal; Clinical Academic Center of Coimbra, CA
  • Ferreira MM; Coimbra Institute for Clinical and Biomedical Research (iCBR) area of Environment Genetics and Oncobiology (CIMAGO), University of Coimbra, Coimbra, Portugal; Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, Coimbra, Portugal; Clinical Academic Center of Coimbra, CA
  • Botelho MF; Coimbra Institute for Clinical and Biomedical Research (iCBR) area of Environment Genetics and Oncobiology (CIMAGO), University of Coimbra, Coimbra, Portugal; Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, Coimbra, Portugal; Clinical Academic Center of Coimbra, CA
  • Marto CM; Institute of Integrated Clinical Practice, Faculty of Medicine, University of Coimbra, Coimbra, Portugal; Coimbra Institute for Clinical and Biomedical Research (iCBR) area of Environment Genetics and Oncobiology (CIMAGO), University of Coimbra, Coimbra, Portugal; Center for Innovative Biomedicine a
  • Carrilho E; Institute of Integrated Clinical Practice, Faculty of Medicine, University of Coimbra, Coimbra, Portugal; Coimbra Institute for Clinical and Biomedical Research (iCBR) area of Environment Genetics and Oncobiology (CIMAGO), University of Coimbra, Coimbra, Portugal; Center for Innovative Biomedicine a
J Vis Exp ; (173)2021 07 08.
Article em En | MEDLINE | ID: mdl-34309590
ABSTRACT
Biomaterials contact directly or indirectly with the human tissues, making it important to evaluate its cytotoxicity. This evaluation can be performed by several methods, but a high discrepancy exists between the approaches used, compromising the reproducibility and the comparison among the obtained results. In this paper, we propose a protocol to evaluate biomaterials cytotoxicity using soluble extracts, which we use for dental biomaterials. The extracts preparation is detailed, from pellets production to its extraction in a culture medium. The biomaterials cytotoxicity evaluation is based on metabolic activity using the MTT assay, cell viability using the Sulphorhodamine B (SBR) assay, cell death profile by flow cytometry, and cell morphology using May-Grünwald Giemsa. Additional to cytotoxicity evaluation, a protocol to evaluate cell function is described based on the expression of specific markers assessed by immunocytochemistry and PCR. This protocol provides a comprehensive guide for biomaterials cytotoxicity and cellular effects evaluation, using the extracts methodology, in a reproducible and robust manner.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Materiais Biocompatíveis Limite: Humans Idioma: En Revista: J Vis Exp Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Materiais Biocompatíveis Limite: Humans Idioma: En Revista: J Vis Exp Ano de publicação: 2021 Tipo de documento: Article